Transcode Therapeutics, Inc. - Common Stock, par value $0.0001 per share (RNAZ)

Historical Holders for Q4 2024

Symbol
RNAZ on Nasdaq
CUSIP
89357L402
Type / Class
Equity / Common Stock, par value $0.0001 per share
Shares outstanding
700K
All holders as of December 31, 2024
Q4 2024
Shares, excl. options
9.91K
Holdings value
$33.4K
% of all portfolios
0%
Grand Portfolio weight change
+0%
Number of holders
4
Number of buys
4
Average Value change %
+0%
Average buys %
+0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Transcode Therapeutics, Inc. - Common Stock, par value $0.0001 per share (RNAZ)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Anson Funds Management LP 9.9% $55.6K 113K Anson Funds Management LP Dec 31, 2024
SABBY MANAGEMENT, LLC 9.9% $34.1K 69.6K SABBY MANAGEMENT, LLC Dec 31, 2024
Tracy Thomas Joseph 5% $17.2K 35K Thomas Joseph Tracy Mar 7, 2025

Institutional Holders of Transcode Therapeutics, Inc. - Common Stock, par value $0.0001 per share (RNAZ)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q4 9.91K $33.4K +$33.4K $3.37 4